Table Info

Table 7.

Biological evaluation of some members of genus Syzygium against several cancer cell lines

N	Species name	Parts of the plant	Solvents	Concentration	Type of cancer	Major finding	Reference
1	Syzygium alternifolium (Wight) Walp.	Leaves	Hexane, methanol	10, 25, 50, and 100 μg/mL	Breast, prostate	The human cancer cell lines MCF-7 and DU-145 had IC₅₀ values of 8.177 μg/mL and 2.687 μg/mL for leaf hexane extract, respectively.	[88]
2	Syzygium calophyllifolium (Wight) Walp.	Bark	Methanol	5, 10, and 20 μg	Breast	When compared to the control, MCF-7 cells cultured with SCBM extract for 24 h lost their original shape at increasing concentrations. Membrane damage, cell rounding, and cell separation from the culture plates were all telltale markers of cell death. At the smallest dose, however, these effects were not observed.	[89]
2	Syzygium calophyllifolium (Wight) Walp.	Leaves	Ethyl acetate	1:1 to 1:64	Monolayer culture	As sample concentration increases, cell viability declines. When the extract was concentrated, further, 88.53% of the cell lines died.	[12]
3	Syzygium anisatum (Vickery) Craven & Biffin	-	-	0–2.0 mg/mL	Glandular, fibroblast, bladder, liver	Caused a 25%–50% death rate in HepG2 hepatocellular cancer cells. Colon cancer cells (HT-29; IC₅₀ = 0.75–1.39 mg/mL), stomach cancer cells (AGS; IC₅₀ = 0.59–1.88 mg/mL), bladder cancer cells (BL13; IC₅₀ = 0.56–1.12 mg/mL), and liver cancer cells (HepG2; IC₅₀ = 0.38–1.36 mg/mL) all had their proliferation inhibited by the extracts. Non-transformed colon cells (CCD-18Co; IC₅₀ > 2.0 mg/mL) and stomach/intestine cells (Hs 738. St/Int; IC₅₀ > 2.0 mg/mL) showed no discernible loss of viability.	[90]
4	Syzygium austral (J.C.Wendl. ex Link) B.Hyland	Fruit	Methanol, aqueous, ethyl acetate	30 μL	Colon, cervical	Against CaCo2 and HeLa cells, the aqueous extracts showed the greatest activity, with IC₅₀ values of 27 μg/mL and 172 μg/mL.	[91]
5	Syzygium myrtifolium Walp.	Leaves	Essential oil	6.25, 12.5, 50, and 100 μg/mL	Colorectal, ovary	The IC₅₀ values for the essential oil were 59.9 μg/mL and 47.5 μg/mL for the HCT-116 and human ovarian teratocarcinoma cells (Pa-1) cell lines, respectively.	[13]
6	Syzygium jambos (L.) Alston	Leaves	Methanol	15 μg/mL (pure compound), 25 μg/mL	Liver	The research confirmed the extract acted on a cellular level positively affecting the apoptotic cell cycle pathway via Bcl-2 and Bax gene expression.	[92]
7	Syzygium paniculatum DC.	Fruits	Ethanol	100, 200, and 400 μg/mL	Pancreatic cancer cells (MiaPaCa-2)	Compared to the chemotherapy drug gemcitabine, the extract (200 μg/mL) dramatically decreased the vitality of MiaPaCa-2 and ASPC-1 pancreatic cancer cells.	[93]
8	Syzygium malaccense (L.) Merr. & L.M.Perry	Fruits	Methanol, aqueous	-	Lung, kidney	In the doses used, the extract’s effects on the two cell lines were not statistically significant.	[81]
9	Syzygium mundagam (Bourd.) Chithra	Bark	Methanol	-	Breast	Reduced ATP levels (47.96%) and elevated lactate dehydrogenase (LDH) levels (40.96%) in MCF-7 cells were indicative of solitary metachronous bone metastasis (SMBM)-induced toxicity.	[94]
10	Syzygium zeylanicum (L.) DC.	Leaves	Methanol	-	-	Both 1:250 and 1:125 had the highest cell viability rates.	[95]
11	Syzygium coriaceum Bosser & J.Guého	Leaves	Aqueous methanol (80%, v/v)	-	-	And at 40 μg/mL, Syzygium coriaceum caused an 88.1% (P < 0.0001) decrease in mitochondrial membrane potential, a 5.7% (P < 0.0001) increase in the number of the cell population in G0/G1, and an increased (P < 0.0001) proportion of cells experiencing apoptotic/necrotic cell death.	[96]
11	Syzygium coriaceum Bosser & J.Guého	Leaves	Aqueous methanol (80%, v/v)	10 μg/mL and 100 μg/mL	Lung carcinoma, liposarm hepatocellular carcinoma	Dose-dependent elevation of ROS was observed after extract treatment in HepG2 cells, with a 4.4-fold rise at 100 mg/mL (P < 0.0001). The dose-dependent reduction in antioxidant enzyme activity mirrored the increase in ROS concentration. At 40 μg/mL (P < 0.0001), glutathione peroxidase activity dropped by 80.5%.	[97]

-: not applicable

Declarations

Author contributions

MDA: Conceptualization, Writing—original draft, Writing—review & editing. HAH: Writing—review & editing, Data curation.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Thampi N, Shalini JV. Bio-prospecting the in-vitro antioxidant and anti-cancer activities of silver nanoparticles synthesized from the leaves of Syzygium samarangense. Int J Pharm Pharm Sci. 2015;7:269–74.

Kumar PS, Febriyanti RM, Sofyan FF, Luftimas DE, Abdulah R. Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines. Pharmacogn Res. 2014;6:350–4. [DOI] [PubMed] [PMC]

Fiqri H, Gaisani A, Adrebi K, Proborini W, Widyanto R. Evaluation of total phenolic, total flavonoid, and in vitro cytotoxic activity of Syzygium cumini extract in cervical cancer cell. J Phys Conf Ser. 2020;1665:12033. [DOI]

Khandaker MM, Mat N, Abdulrahman MD, Ali MA. Morphological and anatomical studies of Syzygium polyanthum (Wight) Walp. (Myrtaceae). MNJ. 2018;70:309–22.

Abdulrahman MD. Review of ethnopharmacology, morpho-anatomy, biological evaluation and chemical composition of Syzygium polyanthum (Wight) Walp. Plant Sci Today. 2021;9:167–77.

Abdulrahman MD, Hasan Nudin N, Khandaker MM, Ali AM, Mat N. In vitro biological investigations on Syzygium polyanthum cultivars. Int J Agric Biol. 2019;22:1399–406.

Abdulrahman M. Antioxidant, alpha glucosidase and antibacterial evaluation of Syzygium mytifolium (Roxb.) Walp. Plant Sci Today. 2021;8:410–5. [DOI]

Hamad A, Mahardika M, Yuliani I, Hartanti D. Chemical constituents and antimicrobial activities of essential oils of Syzygium polyanthum and Syzygium aromaticum. Rasayan J Chem. 2017;10:564–9. [DOI]

Chua LK, Lim CL, Ling APK, Chye SM, Koh RY. Anticancer potential of Syzygium species: a review. Plant Foods Hum Nutr. 2019;74:18–27. [DOI] [PubMed]

10.

Abdulrahman MD, Ali AM, Khandaker MM, Fatihah HNN, Mat N. Discrimination of Syzygium polyanthum (Wight) Walp. cultivars based on ATR-FTIR spectroscopy. Bioscience Res. 2019;15:3635–46.

11.

Abdulrahman MD, Fatihah HNN, Abdul M, Ali M, Mat N, Khandaker M. Phenetic and unsupervised multivariate analysis Syzygium polyanthum (Wight) Walp. Iraqi JAS. 2021;52:249–58. [DOI]

12.

Vignesh R, Puhazhselvan P, Sangeethkumar M, Saranya J, Eganathan P, Sujanapal P. GC-MS analysis, antimicrobial, scavenging ability and cytotoxic activity of leaves of Syzygium calophyllifolium Walp. J Bio Act Prod Nat. 2013;3:121–9. [DOI]

13.

Jena S, Ray A, Sahoo A, Das PK, Dash KT, Kar SK, et al. Chemical composition and biological activities of leaf essential oil of Syzygium myrtifolium from eastern India. J Essent Oil Bear Pl. 2021;24:582–95. [DOI]

14.

Sonawane MS. Dietary benefits of watery rose apple (Syzygium aqueum (Burm. f.) Alston). Int Arch App Sci Tech. 2018;9:126–9.

15.

Dwivedi V, Shrivastava R, Hussain S, Ganguly C, Bharadwaj M. Comparative anticancer potential of clove (Syzygium aromaticum) - an Indian spice - against cancer cell lines of various anatomical origin. Asian Pac J Cancer Prev. 2011;12:1989–93. [PubMed]

16.

El-Saber Batiha G, Alkazmi LM, Wasef LG, Beshbishy AM, Nadwa EH, Rashwan EK. Syzygium aromaticum L. (Myrtaceae): traditional uses, bioactive chemical constituents, pharmacological and toxicological activities. Biomolecules. 2020;10:202. [DOI] [PubMed] [PMC]

17.

Sarrami N, Pemberton M, Thornhill M, Theaker E. Adverse reactions associated with the use of eugenol in dentistry. Br Dent J. 2002;193:257–9. [DOI] [PubMed]

18.

Ayyanar M, Subash-Babu P. Syzygium cumini (L.) Skeels: a review of its phytochemical constituents and traditional uses. Asian Pac J Trop Biomed. 2012;2:240–6. [DOI] [PubMed]

19.

Nadkarni KM. Dr. K.M. Nadkarni’s Indian materia medica: with ayurvedic, unani-tibbi, siddha, allopathic, homeopathic, naturopathic & home remedies, appendices & indexes. Popular Prakashan; 1996.

20.

Shafi P, Rosamma M, Jamil K, Reddy P. Antibacterial activity of Syzygium cumini and Syzygium travancoricum leaf essential oils. Fitoterapia. 2002;73:414–6. [DOI] [PubMed]

21.

Baliga MS, Fernandes S, Thilakchand KR, D’souza P, Rao S. Scientific validation of the antidiabetic effects of Syzygium jambolanum DC (black plum), a traditional medicinal plant of India. J Altern Complement Med. 2013;19:191–7. [DOI] [PubMed]

22.

Anoop M, Bindu A. In-vitro anti-inflammatory activity studies on Syzygium zeylanicum (L.) DC leaves. IJPRR. 2015;4:18–27.

23.

Abdulrahman MD, Ali AM, Fatihah H, Khandaker MM, Mat N. Traditional medicinal knowledge of Malays in Terengganu, Peninsular Malaysia. MNJ. 2018;70:349–64.

24.

Nguyen TL, Rusten A, Bugge MS, Malterud KE, Diallo D, Paulsen BS, et al. Flavonoids, gallotannins and ellagitannins in Syzygium guineense and the traditional use among Malian healers. J Ethnopharmacol. 2016;192:450–8. [DOI] [PubMed]

25.

Loha M, Mulu A, Abay SM, Ergete W, Geleta B. Acute and subacute toxicity of methanol extract of Syzygium guineense leaves on the histology of the liver and kidney and biochemical compositions of blood in rats. Evid Based Complement Alternat Med. 2019;2019:5702159. [DOI] [PubMed] [PMC]

26.

Yassin MT, Al-Askar AA, Mostafa AAF, El-Sheikh MA. Bioactivity of Syzygium aromaticum (L.) Merr. & L.M.Perry extracts as potential antimicrobial and anticancer agents. J King Saud Univ Sci. 2020;32:3273–8. [DOI]

27.

Hesari NG, Tofighi Z, Shirmardi SF, Hashemi SM, Hadjiakhoondi A, Goodarzi S. Possible potential of Astrodaucus genus in development of anticancer drugs. Avicenna J Phytomed. 2021;11:11–21. [PubMed] [PMC]

28.

Kristanti AN, Aung EE, Aminah NS, Takaya Y, Aung HT, Ramadhan R. Bioactive triterpenoids from Indonesian medicinal plant Syzygium aqueum. Open Chem. 2022;20:204–11. [DOI]

29.

Rabeta M, Chan S, Neda G, Lam K, Ong M. Anticancer effect of underutilized fruits. Int Food Res. 2013;20:551–6.

30.

Aung E, Kristanti A, Aminah N, Takaya Y, Ramadhan R, Aung H. Anticancer activity of isolated compounds from Syzygium aqueum stem bark. Rasayan J Chem. 2021;14:312–8. [DOI]

31.

Sobeh M, Braun MS, Krstin S, Youssef FS, Ashour ML, Wink M. Chemical profiling of the essential oils of Syzygium aqueum, Syzygium samarangense and Eugenia uniflora and their discrimination using chemometric analysis. Chem Biodivers. 2016;13:1537–50. [DOI] [PubMed]

32.

Rocchetti G, Lucini L, Ahmed SR, Saber FR. In vitro cytotoxic activity of six Syzygium leaf extracts as related to their phenolic profiles: an untargeted UHPLC-QTOF-MS approach. Food Res Int. 2019;126:108715. [DOI] [PubMed]

33.

Aung EE, Kristanti AN, Aminah NS, Takaya Y, Ramadhan R. Cytotoxicity of butyrospermol and sitosterone from the stem bark of Syzygium aqueum. Trop J Nat Pro Res. 2020;4:899–904.

34.

Ling LT, Radhakrishnan AK, Subramaniam T, Cheng HM, Palanisamy UD. Assessment of antioxidant capacity and cytotoxicity of selected Malaysian plants. Molecules. 2010;15:2139–51. [DOI] [PubMed] [PMC]

35.

Su ZY, Chan YF, Tung YC, Sung PH, Chen PC, Lin ZH, et al. Evaluating skin cancer chemopreventive potential of water extract of Syzygium samarangense leaves through activation of the Nrf2-mediated cellular defense system. S Afr J Bot. 2021;137:303–10. [DOI]

36.

Thampi N, Shalini JV. Anti-proliferative and apoptotic activities of Syzygium samarangense (wax apple) fruits extract against human A549 lung cancer cell lines. Cell. 2015;10:11.

37.

Simirgiotis MJ, Adachi S, To S, Yang H, Reynertson KA, Basile MJ, et al. Cytotoxic chalcones and antioxidants from the fruits of Syzygium samarangense (Wax Jambu). Food Chem. 2008;107:813–9. [DOI] [PubMed] [PMC]

38.

Amor EC, Villaseñor IM, Antemano R, Perveen Z, Concepcion GP, Choudhary M. Cytotoxic C-methylated chalcones from Syzygium samarangense. Pharm Biol. 2007;45:777–83. [DOI]

39.

Yang J, Su JC, Lei XP, Huang XJ, Zhang DM, Ye WC, et al. Acylphloroglucinol derivatives from the leaves of Syzygium samarangense and their cytotoxic activities. Fitoterapia. 2018;129:1–6. [DOI] [PubMed]

40.

Kamada Y, Yakabu H, Ichiba T, Tamanaha A, Shimoji M, Kato M, et al. Castalagin and vescalagin purified from leaves of Syzygium samarangense (Blume) Merrill & L.M. Perry: dual inhibitory activity against PARP1 and DNA topoisomerase II. Fitoterapia. 2018;129:94–101. [DOI] [PubMed]

41.

Kathirvel P, Mini R, Vimaladevi K, Prabhu V, Mariappan A, Karthigai M. In vitro cytotoxicity potential of ethanol extract of Syzygium samarangense (Wt.). KRJ. 2019;6:30–2. [DOI]

42.

Banerjee S, Panda CK, Das S. Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis. 2006;27:1645–54. [DOI] [PubMed]

43.

Aisha AF, Abu-Salah KM, Alrokayan SA, Siddiqui MJ, Ismail Z, Majid AMSA. Syzygium aromaticum extracts as good source of betulinic acid and potential anti-breast cancer. Rev Bras Farmacogn. 2012;22:335–43. [DOI]

44.

Das A, Harshadha K, DK S K, Jayaprakash B. Evaluation of therapeutic potential of eugenol-a natural derivative of Syzygium aromaticum on cervical cancer. Asian Pac J Cancer Prev. 2018;19:1977–85. [DOI] [PubMed] [PMC]

45.

Valizadeh A, Khaleghi AA, Alipanah H, Zarenezhad E, Osanloo M. Anticarcinogenic effect of chitosan nanoparticles containing Syzygium aromaticum essential oil or eugenol toward breast and skin cancer cell lines. BioNanoScience. 2021;11:678–86. [DOI]

46.

Ali I, Naqshbandi MF, Husain M. Cell migration and apoptosis in human lung cancer cells by Clove (Syzygium aromaticum) dried flower buds extract. J Taibah Univ Med Sci. 2019;13:1163–74. [DOI]

47.

Hussain A, Sasidharan S, Ahmed T, Ahmed M, Sharma C. Clove (Syzygium aromaticum) extract potentiates gemcitabine cytotoxic effect on human cervical cancer cell line. Int J Cancer Res. 2009;5:95–104. [DOI]

48.

Permatasari HK, Effendi AB, Qhabibi FR, Fawwaz F, Dominique A. Eugenol isolated from Syzygium aromaticum inhibits HeLa cancer cell migration by altering epithelial-mesenchymal transition protein regulators. J App Pharm Sci. 2021;11:49–53. [DOI]

49.

Khan FA, Akhtar S, Almohazey D, Alomari M, Almofty SA. Extracts of clove (Syzygium aromaticum) potentiate FMSP-nanoparticles induced cell death in MCF-7 cells. Int J Biomater. 2018;2018:8479439. [DOI] [PubMed] [PMC]

50.

Abadi AVM, Karimi E, Oskoueian E, Mohammad GRKS, Shafaei N. Chemical investigation and screening of anti-cancer potential of Syzygium aromaticum L. bud (clove) essential oil nanoemulsion. 3 Biotech. 2022;12:49. [DOI] [PubMed] [PMC]

51.

Fadilah F, Abdurrohman H, Joyo E, Widodo VA, Priawan RP, Yazid F, et al. Differential scanning calorimeter profiling for the determination of nanoparticle ethanol extract of clove (Syzygium aromaticum L.) toward Michigan cancer foundation-7 human breast cancer cell lines. Asian J Pharm. 2018;12:S1451–5.

52.

Permatasari HK, Subali AD, Yusuf M, Holipah H. Proapoptotic activity of essential oils from Syzygium aromaticum, Melaleuca cajuputi, and Cymbopogon nardus on HeLa human cervical cancer cells. J App Pharm Sci. 2022;12:84–94. [DOI]

53.

Venugopal K, Rather H, Rajagopal K, Shanthi M, Sheriff K, Illiyas M, et al. Synthesis of silver nanoparticles (Ag NPs) for anticancer activities (MCF 7 breast and A549 lung cell lines) of the crude extract of Syzygium aromaticum. J Photochem Photobiol B. 2017;167:282–9. [DOI] [PubMed]

54.

Sujatha K, Sirisha KB. Anti-cancer and anti-oxidant activity of essential oils of Rosmarinus officinalis, Azadirachta indica, Syzygium aromaticum and Cymbopogon nardus. J Pharm Phytochem. 2019;8:4493–8.

55.

Azim M. Anti-tumor, antioxidant and antimicrobial and the phenolic constituents of clove flower buds (Syzygium aromaticum). J Microb Biochem Technol. 2014;S8:007. [DOI]

56.

Ryu B, Kim HM, Woo JH, Choi JH, Jang DS. A new acetophenone glycoside from the flower buds of Syzygium aromaticum (cloves). Fitoterapia. 2016;115:46–51. [DOI] [PubMed]

57.

Behbahani BA, Noshad M, Falah F. Study of chemical structure, antimicrobial, cytotoxic and mechanism of action of Syzygium aromaticum essential oil on foodborne pathogens. Potravinarstvo. 2019;13:875–83. [DOI]

58.

Begum S, Ali SN, Farooq AD, Siddiqui F, Siddiqui BS, Ayub A, et al. Volatile constituents and in vitro activity of Syzygium aromaticum flower buds (clove) against human cancer cell lines. Pak J Pharm Sci. 2020;33:2659–65. [PubMed]

59.

Nasomyon T, Charoonratana T. Comparative chemical composition and in-vitro cytotoxic activity of Syzygium aromaticum against selected cancer cell lines. Tro J Nat Pro Res. 2021;5:331–5.

60.

Mostafa AAF, Yassin MT, Al-Askar AA, Al-Otibi FO. Phytochemical analysis, antiproliferative and antifungal activities of different Syzygium aromaticum solvent extracts. J King Saud Univ Sci. 2023;35:102362. [DOI]

61.

Thenmozhi T. Functionalization of iron oxide nanoparticles with clove extract to induce apoptosis in MCF-7 breast cancer cells. 3 Biotech. 2020;10:82. [DOI] [PubMed] [PMC]

62.

Karimi A, Moradi MT, Lorigooini Z, Hashemi L, Alidadi S, Saeedi M. Antiproliferative and apoptotic effect of dried flower buds of Syzygium aromaticum L. extract on human cervical cancer (Hela) cells. J Rep Pharm. 2018;7:130–7.

63.

Aksono EB, Latifah AC, Suwanti LT, Haq KU, Pertiwi H. Clove flower extract (Syzygium aromaticum) has anticancer potential effect analyzed by molecular docking and Brine Shrimp Lethality Test (BSLT). Vet Med Int. 2022;2022:5113742. [DOI] [PubMed] [PMC]

64.

Barh D, Viswanathan G. Syzygium cumini inhibits growth and induces apoptosis in cervical cancer cell lines: a primary study. Ecancermedicalscience. 2008;2:83. [DOI] [PubMed] [PMC]

65.

Khodavirdipour A, Zarean R, Safaralizadeh R. Evaluation of the anti-cancer effect of Syzygium cumini ethanolic extract on HT-29 colorectal cell line. J Gastrointest Cancer. 2021;52:575–81. [DOI] [PubMed]

66.

Goyal P, Verma P, Sharma P, Parmar J, Agarwal A. Evaluation of anti-cancer and anti-oxidative potential of Syzygium cumini against benzo[a] pyrene (BaP) induced gastric carcinogenesis in mice. Asian Pac J Cancer Prev. 2010;11:753–8. [PubMed]

67.

Li L, Mangali S, Kour N, Dasari D, Ghatage T, Sharma V, et al. Syzygium cumini (jamun) fruit-extracted phytochemicals exert anti-proliferative effect on ovarian cancer cells. J Cancer Res Ther. 2021;17:1547–51. [DOI] [PubMed]

68.

Khasanah U, Adiningsih OR, Anggraeni ED, Uliyah FU, Ramadhani AI, Saraswati AAD, et al. Phytochemical screening, total phenolic content and cytotoxic activity of seed, leaves, and pulp from Syzygium cumini against breast cancer cell culture 4T1. Res J Pharmacogn Phytochem. 2022:145–9. [DOI]

69.

Aqil F, Gupta A, Munagala R, Jeyabalan J, Kausar H, Sharma RJ, et al. Antioxidant and antiproliferative activities of anthocyanin/ellagitannin-enriched extracts from Syzygium cumini L. (Jamun, the Indian blackberry). Nutr Cancer. 2012;64:428–38. [DOI] [PubMed] [PMC]

70.

Ezhilarasan D, Apoorva VS, Ashok Vardhan N. Syzygium cumini extract induced reactive oxygen species-mediated apoptosis in human oral squamous carcinoma cells. J Oral Pathol Med. 2019;48:115–21. [DOI] [PubMed]

71.

Yadav SS, Meshram G, Shinde D, Patil R, Manohar SM, Upadhye MV. Antibacterial and anticancer activity of bioactive fraction of Syzygium cumini L. seeds. HAYATI J Biosci. 2011;18:118–22. [DOI]

72.

Parmar J, Sharma P, Verma P, Goyal P. Chemopreventive action of Syzygium cumini on DMBA-induced skin papillomagenesis in mice. Asian Pac J Cancer Prev. 2010;11:261–5. [PubMed]

73.

Abd E-MMA, Sayed AF, Emad AS, Hany AES. Syzygium cumini (pomposia) active principles exhibit potent anticancer and antioxidant activities. Afr J Pharm Pharmacol. 2011;5:948–56.

74.

Siddika A, Das PK, Asha SY, Aktar S, Tareq AR, Rakib A, et al. Antiproliferative activity and apoptotic efficiency of Syzygium cumini bark methanolic extract against EAC cells in vivo. Anticancer Agents Med Chem. 2021;21:782–92. [DOI] [PubMed]

75.

Artanti N, Maryani F, Dewi RT, Handayani S, Dewijanti ID, Meilawati L, et al. In vitro antidiabetic, antioxidant and cytotoxic activities of Syzygium cumini fractions from leaves ethanol extract. Ind J Cancer Chemoprev. 2019;10:24–9. [DOI]

76.

Parmar J, Sharma P, Verma P, Sharma P, Goyal PK. Elimination of deleterious effects of DMBA-induced skin carcinogenesis in mice by Syzygium cumini seed extract. Integr Cancer Ther. 2011;10:289–97. [DOI] [PubMed]

77.

Solai Prakash AK, Devaraj E. Cytotoxic potentials of S. cumini methanolic seed kernel extract in human hepatoma HepG2 cells. Environ Toxicol. 2019;34:1313–9. [DOI] [PubMed]

78.

Aqil F, Jeyabalan J, Munagala R, Singh IP, Gupta RC. Prevention of hormonal breast cancer by dietary jamun. Mol Nutr Food Res. 2016;60:1470–81. [DOI] [PubMed] [PMC]

79.

Azzaz N, Hamed SE, Mohamed A. Antimicrobial and anticancer activities of Syzygium cumini extracts. J Agric Chem Biotech. 2022;13:35–8. [DOI]

80.

Islam S, Nasrin S, Khan MA, Hossain A, Islam F, Khandokhar P, et al. Evaluation of antioxidant and anticancer properties of the seed extracts of Syzygium fruticosum Roxb. growing in Rajshahi, Bangladesh. BMC Complement Altern Med. 2013;13:142. [DOI] [PubMed] [PMC]

81.

Gibbert L, Sereno AB, de Andrade MTP, da Silva MAB, Miguel MD, Montrucchio DP, et al. Nutritional composition, antioxidant activity and anticancer potential of Syzygium cumini (L.) and Syzygium malaccense (L.) fruits. Res Soc Dev. 2021;10:e5210413743. [DOI]

82.

Nordin ML, Othman AA, Kadir AA, Shaari R, Osman AY, Mohamed M. Antibacterial and cytotoxic activities of the Syzygium polyanthum leaf extract from Malaysia. Vet World. 2019;12:236–42. [DOI] [PubMed] [PMC]

83.

Sulistiyani S, Falah S, Wahyuni WT, Sugahara T, Tachibana S, Suminto S. Cellular mechanism of the cytotoxic effect of extracts from Syzygium polyanthum leaves. Am J Drug Disc Dev. 2014;4:90–101. [DOI]

84.

Kusuma IW, Kuspradini H, Arung ET, Aryani F, Min YH, Kim JS, et al. Biological activity and phytochemical analysis of three Indonesian medicinal plants, Murraya koenigii, Syzygium polyanthum and Zingiber purpurea. J Acupunct Meridian Stud. 2011;4:75–9. [DOI] [PubMed]

85.

Koval A, Pieme CA, Queiroz EF, Ragusa S, Ahmed K, Blagodatski A, et al. Tannins from Syzygium guineense suppress Wnt signaling and proliferation of Wnt-dependent tumors through a direct effect on secreted Wnts. Cancer Lett. 2018;435:110–20. [DOI] [PubMed]

86.

AlQathama A, Ezuruike UF, Mazzari AL, Yonbawi A, Chieli E, Prieto JM. Effects of selected Nigerian medicinal plants on the viability, mobility, and multidrug-resistant mechanisms in liver, colon, and skin cancer cell lines. Front Pharmacol. 2020;11:546439. [DOI] [PubMed] [PMC]

87.

Uchogu AP, Yahaya TA, Salawu OA, Adamu MA, Ameh FS. Anti-proliferative potential of some common vegetables and plants in Nigeria. J Pharm DevInd Pharm. 2020;2:11–9.

88.

Komuraiah B, Chinde S, Niranjana Kumar A, Satya Srinivas K, Venu C, Kotesh Kumar J, et al. Isolation of phytochemicals from anticancer active extracts of Syzygium alternifolium Walp. leaf. Pharmacogn J. 2014;6:83–5.

89.

Chandran R, Abrahamse H, Parimelazhagan T. Cytotoxic, analgesic and anti-inflammatory properties of Syzygium calophyllifolium bark. Biomed Pharmacother. 2018;103:1079–85. [DOI] [PubMed]

90.

Sakulnarmrat K, Fenech M, Thomas P, Konczak I. Cytoprotective and pro-apoptotic activities of native Australian herbs polyphenolic-rich extracts. Food chem. 2013;136:9–17. [DOI] [PubMed]

91.

Jamieson N, Sirdaarta J, Cock I. The anti-proliferative properties of Australian plants with high antioxidant capacities against cancer cell lines. Phcog Commn. 2014;4:71–82.

92.

Thamizh Selvam N, Acharya M, Venkatakrishnan V, Murugesan S. Effect of methanolic extract of (Linn.) Alston leaves at intra Syzygium jambos cellular level in selective liver cancer cell line: molecular approach for its cytotoxic activity. Adv Pharm J. 2016;1:139–43.

93.

Vuong QV, Hirun S, Chuen TL, Goldsmith CD, Bowyer MC, Chalmers AC, et al. Physicochemical composition, antioxidant and anti-proliferative capacity of a lilly pilly (Syzygium paniculatum) extract. J Herb Med. 2014;4:134–40. [DOI]

94.

Chandran R, George BP, Abrahamse H. Anti-proliferative, analgesic and anti-inflammatory properties of Syzygium mundagam bark methanol extract. Molecules. 2020;25:2900. [DOI] [PubMed] [PMC]

95.

Prasad P, Varghese AT, Jose A, Athul R, Akash P. Evaluation of phytochemical, antioxidant, anti-inflammatory antimicrobial, anti-cancerous and wound healing potential of Syzygium zeylanicum. Ann Pharma Res. 2022;10:705–17.

96.

Rummun N, Serag A, Rondeau P, Ramsaha S, Bourdon E, Bahorun T, et al. Antiproliferative activity of Syzygium coriaceum, an endemic plant of Mauritius, with its UPLC-MS metabolite fingerprint: a mechanistic study. PloS one. 2021;16:e0252276. [DOI] [PubMed] [PMC]

97.

Rummun N, Pires E, McCullagh J, Claridge TW, Bahorun T, Li WW, et al. Methyl gallate–rich fraction of Syzygium coriaceum leaf extract induced cancer cell cytotoxicity via oxidative stress. S Afr J Bot. 2021;137:149–58. [DOI]

98.

Jaganathan SK, Supriyanto E. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules. 2012;17:6290–304. [DOI] [PubMed] [PMC]

99.

Gonçalves BM, Mendes VI, Silvestre SM, Salvador JA. Design, synthesis, and biological evaluation of new arjunolic acid derivatives as anticancer agents. RSC Med Chem. 2023;19:313–31.

100.

Subramanian A, John A, Vellayappan M, Balaji A, Jaganathan S, Supriyanto E, et al. Gallic acid: prospects and molecular mechanisms of its anticancer activity. RSC Adv. 2015;5:35608–21. [DOI]

101.

Nagappan A, Park HS, Hong GE, Yumnam S, Lee HJ, Kim DH, et al. Anti-cancer and anti-inflammatory properties of Korean Citrus fruits (Citrus aurantium L.). J Kor Clin Health Sci. 2014;2:73–8. [DOI]